Blood DNA methylation pattern is altered in mesial temporal lobe epilepsy

Area of Science:

• Epigenetics
• Neuroscience
• Genomics

Background:

• Mesial temporal lobe epilepsy (MTLE) is a prevalent neurological disorder.
• The association between MTLE and peripheral epigenetic modifications remains largely unexplored.

Purpose of the Study:

• To investigate whole-genome DNA methylation patterns in the blood of MTLE patients.
• To identify differentially methylated genes and pathways in MTLE.
• To explore correlations between epigenetic changes and clinical features of MTLE.

Main Methods:

• Human Methylation 450K BeadChip assay was used to compare DNA methylation in 30 MTLE patients and 30 controls.
• Bioinformatics profiling was employed to analyze differentially methylated genes and pathways.

Main Results:

• Significant differences in DNA methylation were observed at 216 sites between MTLE patients and controls (P < 1.03e-07).
• 164 sites showed hypermethylation and 52 showed hypomethylation, primarily in coding regions and promoters.
• Differentially methylated genes are linked to pathways involved in anion binding, oxidoreductant activity, growth regulation, skeletal development, and drug metabolism.

Conclusions:

• Peripheral epigenetic alterations are evident in MTLE patients.
• These changes may contribute to disease pathogenesis and could serve as potential biomarkers.
• Further translational research is recommended to explore the clinical implications of these findings.